Related by context. All words. (Click for frequent words.) 68 Oral Fluid 67 NDA Submission 67 Interferon Gamma 66 Pharmacodynamic 66 CHMP Opinion 66 Results Confirm 66 Pivotal Phase III 66 Tumor Response 65 Cardiotoxicity 65 Phase IIB 65 Cardiac Marker 65 Phase III Clinical Trial 65 Antitumor 65 Clinical Trial Results 65 IND Application 65 Demonstrates Positive 65 Phase 1b Clinical Trial 65 Clinical Trial Data 65 Prognostic Value 65 Aurora Kinase 65 Systemic Delivery 65 Cytotoxicity 65 Diagnostic Tests 65 STRIDE PD 65 Bioequivalence 65 Nicotine Vaccine 64 Cervical Dysplasia 64 Immunohistochemical 64 TB Vaccine 64 Drug Candidate 64 Prolongs Survival 64 Novel Inhibitor 64 Test Detects 64 Placebo Controlled Trial 64 Prostate Cancer Vaccine 64 Breast Density 64 Therapeutic Vaccine 64 Alkaline Phosphatase 64 Respiratory Virus 64 Renal Function 64 Phase 2a Trial 64 Echocardiographic 64 Anticancer Drug 64 Lupus Drug 64 Dose Escalation 64 Glufosfamide 64 IND Filing 64 JAK Inhibitor 64 Anti Tumor Activity 64 Tyrosine Kinase Inhibitor 64 Anti Inflammatory Drug 64 Severe Sepsis 64 Clinical Validation 64 Phase 2b Clinical Trial 64 Statistically Significant 63 Infected Patients 63 Diamyd Medical Diamyd 63 Interferon Beta 63 Infectivity 63 Adjuvant Treatment 63 Prospective Randomized 63 Adjuvant Chemotherapy 63 Oral Calcitonin 63 Salivary 63 Pafuramidine 63 Lymphoid 63 Treating Chronic 63 Intra Arterial 63 Diabetic Nephropathy 63 Hepatitis B Virus 63 CRMD# 63 Anti Tumor 63 Shows Promising 63 Hormone Refractory Prostate Cancer 63 Medullary Thyroid Cancer 63 Pharmacokinetic Study 63 Phase IIA 63 Universal Flu Vaccine 63 Initiate Phase 63 PANVAC VF 63 Fast Track Status 63 Novel Antibiotic 63 Rotavirus Vaccine 63 FDA Approvable Letter 63 Unresectable 63 Novel Therapeutic 63 Myocardial Perfusion Imaging 63 Antiangiogenic 63 GRAVITAS trial 63 Radiation Induced 63 Pivotal Phase II 62 Clinical Outcome 62 Meets Primary Endpoint 62 Techni lab 62 Improves Survival 62 Premarket Approval 62 Diabetic Foot Ulcer 62 Epidermal Growth Factor Receptor 62 Microalbuminuria 62 Hsp# Inhibitor 62 IMPACT DCM 62 Metastatic Melanoma 62 Schizophrenia Treatment 62 Begin Clinical Trials 62 Dose Ranging Study 62 Left Ventricular 62 Lung Cancer Drug 62 Pivotal Clinical Trial 62 Iron Overload 62 Ranolazine 62 Patient Enrollment 62 Immunotherapeutic 62 Phase 2b Trial 62 APTIMA HPV assay 62 Gastrointestinal Stromal Tumors 62 Activator CK # 62 Phase IIb III 62 Confirmatory Phase 62 Resubmission 62 Initiates Clinical 62 Antigen CEA 62 SPRYCEL ® 62 GLP toxicology studies 62 Completes Patient Enrollment 62 Hematopoietic 62 preclinical pharmacokinetic 62 Aeolus Pharmaceuticals Announces 62 JAK2 Inhibitor 62 Chemoradiation 62 Predict Risk 62 Multiple Ascending Dose 62 Vaccine Candidate 62 Phase IIb Clinical Trial 62 Approvable 62 Pharmacokinetic PK 62 Vicor Technologies Announces 62 Randomized Clinical Trials 62 BRIM3 62 Daptomycin 62 Neoadjuvant Chemotherapy 62 Skin Irritation 62 Antiviral Activity 62 Seasonal Influenza Vaccine 62 Unfractionated Heparin 62 Liver Toxicity 62 Immunogenicity 62 Desorption 62 FDA Approvals 62 Degarelix 62 Combination Treatment 62 Risk Stratification 62 Randomized Phase 62 pharmacodynamic parameters 62 Smooth Muscle 62 Molecular Diagnostic 62 Adjuvant Therapy 61 Serologic 61 LungAlert TM 61 Tigecycline 61 D Dimer 61 Non inferiority 61 Shows Promise Against 61 Efficacy Trial 61 Reproducibility 61 HDAC Inhibitor 61 Bacteremia 61 NMDA Receptor 61 Estrogen Receptor 61 Plaque Psoriasis 61 preclinical efficacy 61 Protease Inhibitor 61 Reperfusion Injury 61 Combo Therapy 61 Data Suggest 61 Granulocyte Colony Stimulating Factor 61 Rheumatoid Arthritis Patients 61 BioSante Pharmaceuticals Reports 61 Pegylated 61 RNAi Therapeutic 61 Phase IIb Trial 61 Aggressive Prostate Cancer 61 Pivotal Phase 61 Histologic 61 Oral Fingolimod 61 Crowflight Announces 61 Hepatitis C Infection 61 biodistribution studies 61 Percutaneous Tibial Nerve Stimulation 61 Intravenous Formulation 61 Main Outcome Measure 61 Teva Provides Update 61 Protein Synthesis 61 Truvada tablets 61 NPM1 mutation 61 co receptor tropism 61 Sipuleucel T 61 Patient Enrolment 61 Achieves Primary Endpoint 61 fosbretabulin 61 Metastatic Renal Cell Carcinoma 61 Uterine Cancer 61 Thorough QT 61 Accelerated Approval 61 OvaRex MAb 61 Enzyme Leach 61 Demonstrates Potent 61 Phase III Clinical Trials 61 Breast Tissue 61 Long Term Efficacy 61 Successfully Completes Phase 61 Initiate Clinical Trial 61 Submits NDA 61 Solubility 61 Smallpox Vaccine 61 #F FDG PET 61 Endometrial Cancer 61 Xelox 61 Investigational Treatment 61 Preclinical Study 61 Vaccine Trial 61 Fulvestrant 61 Medicure Announces 61 Drug Resistant 61 Recombinant Human 61 HDL Selective Delipidation 61 Renal Cell Carcinoma 61 Hepatocellular Carcinoma 61 RE MODEL 61 Antitumor Activity 61 Activity Assay 61 Demonstrate Significant 61 Malaria Vaccine 61 Pivotal Study 61 Disease Progression 61 Demonstrated Significant 61 Phase Ib Clinical Trial 61 Cytochrome P# 61 Investigational Agent 61 Fungal Infections 61 Desvenlafaxine Succinate 61 Improves Outcomes 61 Files IND 61 Dalbavancin 61 ATAC Arimidex Tamoxifen Alone 61 Inactivation 61 Cardiac Markers 61 Ebola Vaccine 61 Dendritic Cells 61 R# #mg BID 61 NuroPro ® 61 Metabolic Disorder 61 Randomised 61 Phase III Trial 61 Biomarker Study 61 Fabry Disease 61 BLA filing 61 Kamada AAT 61 Phase IIa Clinical Trial 61 Cancer Vaccines 61 pharmacokinetic PK study 60 Rheumatoid Arthritis Drug 60 UPLYSO 60 BAL# [002] 60 Protein Expression 60 Retest 60 dual endothelin receptor antagonist 60 Coronary CTA 60 enzyme immunoassay EIA 60 Mutation Detection 60 Hematological 60 Improved Survival 60 NuroPro R 60 Adverse Event 60 inhaled AAT 60 Monoclonal 60 Circulating Tumor Cells 60 Prostate Cancer Progression 60 Silodosin 60 Synthetic Peptide 60 Commences Phase 60 Therapy Reduces 60 Pandemic Influenza Vaccine 60 Survival Benefit 60 Diastolic Heart Failure 60 Targeted Therapy 60 Hepatotoxicity 60 Inhaled Nitric Oxide 60 Dupuytren Contracture 60 Epilepsy Drug 60 Pooled Analysis 60 Breast Cancer Recurrence 60 Cholesterol Lowering Drug 60 CHAMPION PCI 60 Shows Efficacy 60 Randomized Phase II 60 Immunomedics Announces 60 Immunosuppressant 60 Randomized Clinical Trial 60 Helps Predict 60 Prophylactic Treatment 60 Improve Survival 60 Tuberculosis Vaccine 60 Stent Restenosis 60 Sentinel Lymph Node Biopsy 60 Aromatase Inhibitors 60 Combination REOLYSIN R 60 Assay Kits 60 Iloperidone 60 Therapeutic Efficacy 60 NADiA 60 Demonstrates Significant 60 Cites Positive 60 Non Inferiority 60 Chronic Renal Failure 60 Lipid Levels 60 Mammographic 60 Testwork 60 Prognostic 60 Pegylated Liposomal Doxorubicin 60 Septin9 60 Phase 2a Clinical Trial 60 Autologous Stem Cell Transplantation 60 Confirms Efficacy 60 Potent Antiviral Activity 60 lucinactant 60 haematologic 60 Gout Drug 60 Blood Pressure Drug 60 Present Preclinical Data 60 Expedited Review 60 Phase 2b Study 60 Acute Heart Failure 60 p# antigen 60 Septin 9 60 NMP# 60 GRAS Status 60 Antiviral Drugs 60 Unmet Medical 60 B Cell Lymphoma 60 Treatment Naive HIV 60 Hematologic 60 Immunomodulatory 60 Inhaled Insulin 60 Advanced Melanoma 60 IIa Clinical Trial 60 Taro Receives 60 Acute Decompensated Heart Failure 60 Gastric Cancer 60 Immunosuppression 60 Thymosin Beta 4 60 Antidepressant Treatment 60 Localized Prostate Cancer 60 See CLINICAL PHARMACOLOGY 60 Therapeutic Antibody 60 Endometrial 60 Receptor Antagonists 60 Liver Function 60 Tumor Targeting 60 Epratuzumab 60 mineralogical studies 60 Cannabinoid 60 Angiogenic 60 Allogeneic 60 Lung Injury 60 Gene Variants 60 Immunologic 60 Hyperparathyroidism 60 Preclinical Data 60 Roche cobas 60 Tezampanel 60 Breast Cancer Cells 60 FDA Accepts 60 Hormonal Therapy 60 MAGE A3 ASCI 60 MEND CABG 60 Protease Inhibitors 60 Renal Cancer 60 Skeletal Muscle 60 Alemtuzumab 59 Bosutinib 59 Phase 2a clinical trials 59 Phase 1b clinical trials 59 Gene Expression Analysis 59 Predictive Value 59 Vaccine Protects Against 59 Hematopoietic Stem Cells 59 Refractory Angina 59 Novel Protein 59 Pandemic Flu Vaccine 59 Epithelial Cell 59 biostatistical analysis 59 Thyroid Function 59 Entry Inhibitor 59 Metallurgical testwork 59 Toxicological 59 Stable Angina 59 Metastatic Prostate Cancer 59 plasma pharmacokinetics 59 Dose Finding 59 TransVax 59 bioFILM PA TM 59 IDI MRSA 59 AST ALT 59 Myelodysplastic Syndromes 59 Transfection 59 Mutational 59 Cardiogenic Shock 59 Safinamide 59 Vitaxin 59 Contrast Agents 59 Catheter Associated 59 Follicular Lymphoma 59 Interferon Alpha 59 Predisposition 59 preliminary metallurgical testwork 59 Stent Thrombosis 59 Hepatitis B Vaccine 59 Fibrinogen 59 Avian Flu Vaccine 59 Watchful Waiting 59 Kidney Function 59 tumorigenicity 59 Antibody Discovery 59 Mammalian Cell Culture 59 Benign Prostatic Hyperplasia 59 Ozarelix 59 DispersinB R 59 Pulmonary Arterial Hypertension 59 Roche COBAS 59 Valve Replacement 59 First Patient Enrolled 59 Oncotype DX colon cancer 59 Genetic Tests 59 Nymox NX 59 Could Predict 59 Transdermal Delivery 59 PEG IFN 59 budesonide foam 59 Chronic Lyme Disease 59 Immune Responses 59 Preclinical Models 59 Monoclonal Antibody 59 Initiates Enrollment 59 Differential Diagnosis 59 Diagnostic Criteria 59 HCV replicon 59 Antithrombin 59 CLIA Waiver 59 Squamous Cell Carcinoma 59 Hematological Cancers 59 RT qPCR 59 Phase Ib study 59 Protein Biomarker 59 Pivotal Trials 59 Crystallographic 59 Darinaparsin 59 Homeostasis 59 Gets FDA Clearance 59 PDUFA Date 59 BEXXAR Therapeutic Regimen 59 Fondaparinux 59 Interferon Alfa 59 Clinical Evaluation 59 Drug Fails 59 Brain Metastases 59 Clinical Efficacy 59 Inflammatory Markers 59 Mucosal 59 Pivotal Trial 59 XPEL Announces 59 Malignant Glioma 59 Virus Infection 59 PhenoSense 59 Chemokine Receptor 59 Predict Breast Cancer 59 Co Receptor Tropism 59 Known hypersensitivity 59 Experimental Vaccine 59 Potent Anti 59 Analytical Method 59 Progenitor Cells 59 Topline Results 59 Cytogenetic 59 Investigational Drugs 59 Treated Patients 59 Oral Insulin 59 heap leach amenability 59 Reevaluation 59 Predict Response 59 glycopeptide 59 Anticancer Agent 59 Gene Variant 59 PROSTASCINT R 59 RNAi Therapeutics 59 Hepatitis C Treatment 59 Adult Stem Cell Therapy 59 OvaRex R 59 Isotopic 59 Illumina GoldenGate 59 Permit Approval 59 Heap leach 59 Acute Ischemic Stroke 59 Soft Tissue Sarcoma 59 Appears Safe 59 Quantitation 59 Radical Prostatectomy 59 VP# [004] 59 phase Ib 59 Colorectal Screening 59 VIVUS Announces 59 II Clinical Trial 59 Clinically Significant 59 Flow cytometry 59 Levels Linked 59 Gene Mutation 59 Mechanistic 59 FDG-PET/CT 59 Pharmacogenetic 59 Oral Insulin Capsule 59 Bone Mineral Density 59 Genetic Mutation 59 Prostate AdenoCarcinoma Treatment 59 Late Breaker 59 Randomized Evaluation 59 Metastatic Colorectal Cancer 59 HIV Integrase 59 Patients Receiving 59 Esophagitis 59 NS5A 59 ImmuKnow R 59 Minimally Invasive Treatment 59 Contrast Enhanced 59 Initiates Clinical Trial 59 Single Dose 59 Apoptotic 59 molecular diagnostic assay 59 myocardial necrosis 59 Blood Pressure Lowering 59 Sevelamer 59 Drug Prevents 59 histamine dihydrochloride 59 COSTAR II 59 Randomized Double blind 59 NEUVENGE 59 Sustained Efficacy 59 Tesamorelin 59 Immunoassays 59 Initiated Phase 59 Gas Chromatography Mass Spectrometry 59 Androgen 59 Histological 59 Sensitivity Analysis 59 Anti Clotting Drug 59 5alpha reductase 59 Relapsing Remitting Multiple Sclerosis 59 Investigational Compound 59 Demonstrates Efficacy 59 Signaling Pathways 59 Gas Chromatography 59 Lymphocytic 59 Phase 1a clinical 58 Prognostic Factors 58 Initiate Phase II 58 Cinacalcet HCl 58 Coronary Artery Bypass Graft 58 Identifies Potential 58 Cardiac Troponin 58 Monotherapy 58 FDA Clearance 58 Peginterferon Alfa 2a 58 Spinal Fluid 58 Oritavancin 58 Intravascular 58 Vaccine Adjuvants 58 Tumor Marker 58 Stent Placement 58 Cyanidation 58 pharmacokinetic PK profile 58 Angiox ® 58 Dacogen TM 58 intravenous recombinant 58 Vitro Activity 58 Drug Shows Promise 58 Tesmilifene 58 Glatiramer Acetate 58 Antibiotic Treatment 58 Significantly Improved 58 Cervista HPV HR 58 Further Validates 58 FDA Okays 58 Hypotension 58 Phase III Pivotal Trial 58 Patients Treated With 58 Treatment Regimen 58 Nonclinical 58 Less Invasive 58 Aortic Stenosis 58 Prostate Cancer Treatment 58 Thyroid Hormone 58 Cervista HPV 58 Vitro Diagnostic 58 Genetic Markers 58 Regression Analysis 58 Mantoux test 58 Pralatrexate 58 PNA FISH TM 58 Measles Vaccine 58 AMPAKINE CX# 58 Postdoctoral Position 58 Carotid Artery Stenting 58 Anthrax Vaccine 58 Histopathologic 58 Gene Variation 58 Technological Advances 58 Abbott RealTime 58 evaluating mipomersen 58 Initiates Phase III 58 mediated inhibition 58 Myocardial Ischemia 58 Trial Evaluating 58 Temsirolimus 58 Non Invasive Treatment 58 Active Ulcerative Colitis 58 Initiates Phase II 58 Pluripotent Stem Cells 58 Amniotic Fluid 58 solithromycin 58 Treatment Shows Promise 58 FDA Clears 58 Study Shows Benefits 58 Pharmacologic 58 Hormone Receptor Positive 58 Laryngeal Cancer 58 confirmatory 58 MAQC 58 Zenvia Phase III 58 Val HeFT 58 Vertebral Fracture 58 HCV Infection 58 Clinical Trial Enrollment 58 OvaDx 58 Cardiac Biomarkers 58 Potent Inhibitor 58 Postmenopausal Osteoporosis 58 Genetic Variation 58 Postmarketing 58 Ocrelizumab 58 miRview mets 58 T SPOT.TB 58 metastatic malignant 58 Low Dose 58 thorough QT 58 Sample Preparation 58 Cancer Recurrence 58 multigene expression test 58 Files Investigational 58 Thromboembolic 58 Lung Cancer Trial 58 Reverse Transcriptase 58 TPMT 58 PENNVAX B 58 Fracture stimulation 58 Long Term Survival 58 rxRNA 58 Somatostatin 58 Preliminary Findings 58 miRview meso 58 Stem Cell Treatment 58 CLINICAL PHARMACOLOGY 58 Coronary Angiography 58 REVIVE Diabetes 58 Rotavirus Vaccines 58 Correlative 58 Drug Formulation 58 Expanded Indication 58 Enzyme Replacement Therapy 58 Aptamer 58 Septic Shock 58 Clinical Relevance 58 Neuroprotective Effects 58 SNT-MC#/idebenone 58 EGFR HER2 58 Orally Active 58 MGd 58 bronchoalveolar lavage 58 tumor necrosis 58 Randomized controlled 58 Investigational Drug 58 Cytotoxic 58 Radiation Dose 58 RhuDex R 58 Ultrasensitive 58 ara C 58 AVI BioPharma Announces 58 alpha#beta# integrin 58 Phase #b/#a clinical 58 Antigen Specific 58 Suicidality 58 Phase III Trials 58 Oropharyngeal 58 Enzyme Linked Immunosorbent Assay 58 Lactate 58 Pharmacokinetic 58 Phase Ib clinical 58 Carotid Endarterectomy 58 Demonstrates Ability 58 immunohistochemical analysis 58 RhuDex 58 Supplemental Biologics License Application 58 Skin Lesions 58 Combination Therapy 58 Forodesine HCl 58 Optimer Pharma 58 Inflammatory Arthritis 58 Aflibercept 58 Bacteriological 58 eTag assays 58 Analytical Tool 58 Hemodialysis Patients 58 Attenuates 58 Chemotherapy Regimen 58 Polymerase Chain Reaction 58 BioElectronics Announces 58 AnaSpec Introduces 58 Polymorphism 58 PROVENGE ® 58 Androgen Receptor 58 Colorectal Cancer Patients 58 Histopathological 58 Immunostimulatory 58 Nanoemulsion 58 Pharmacodynamics 58 Secretase 58 Bulk Sampling Program 58 Demonstrates Potential 58 NYSE Amex Listing 58 Genomic Grade 58 rhLF 58 Blood Clotting 58 phase IIIb 58 Susceptibility Testing 58 Left Ventricular Dysfunction 58 Fibrin Sealant 58 pain palliation 58 preclinical pharmacology 58 Elagolix 58 Novel Vaccine 58 Controlled Trial 58 Vicriviroc 58 Antiplatelet Therapy 58 Granted Orphan Drug 58 Platelet Function 58 Raloxifene STAR 58 Phenotypic 58 DNA Methylation 58 Chronic Hepatitis C 58 Moxifloxacin 58 Oncotype 58 Bacterial Contamination 58 Breast Tumors 58 hematological parameters 58 Transdermal Patch 58 pharmacodynamic PD 58 bFGF 58 Installers Drug 58 Chronic Liver Disease 58 Diabetic Kidney Disease 58 Carotid Stenting 58 Tumor Growth 58 Kinase Inhibitor 58 Integrase Inhibitor 58 Patent Covering 58 Double Blind Placebo 58 Preliminary metallurgical 58 Peripheral Arterial 58 Asthma Treatment 58 BPZ Energy Announces 58 Angiographic 58 riociguat 58 prospective multicentre 58 NSABP B 58 Bayer HealthCare Onyx Pharmaceuticals 58 Calcium Acetate 58 tramiprosate Alzhemed TM 58 CYP#A# CYP#D# 58 Thermal Conductivity 58 PHASE III 58 PROCLEIX 58 GTC recombinant form 58 Factor VIIa 58 histopathological 58 Gene Linked 58 EDEMA3 trial 58 Results Indicate 58 Orthostatic Hypotension 58 Total Knee Arthroplasty 58 ThermoDox ® clinical 58 Nebulized 58 Novel Mechanism 58 Magnetic Separation 58 BRAF V#E mutation 58 Erythropoietic 58 sargramostim 58 Repeatability 58 Molecular Mechanism 58 Treatment Outcome 58 Urine Test 58 Advanced Colorectal Cancer 58 Indomethacin 58 pharmacodynamic biomarkers 58 Treatment Regimens 58 Multicenter Phase 58 Archexin 58 synDNA TM 58 Guidelines Issued 58 PROSTVAC ® 58 TransVax tm 58 ASCO GU 58 confirmatory clinical 58 Analyte 58 Implantable Device 58 Adenomas 58 icatibant 58 Mouse Model 58 Secondary Hyperparathyroidism 58 Patellofemoral 58 immunohistochemical 58 Viral Suppression 58 immunotoxicity 58 Ischemic 58 Recurrent Breast Cancer 58 Geochemical analyzes 57 Alferon N 57 Wound Dressing 57 Virologic 57 Announce Collaboration Agreement 57 Therapeutic Potential 57 Detect Lung Cancer 57 viral kinetics 57 #F FDG PET CT 57 mg/m2 cohort 57 Innate Immune 57 Subtype 57 Well Tolerated 57 Dengue Virus 57 Hematopoietic Stem Cell Transplantation 57 PROSTVAC TM 57 Orphan Status 57 Bioavailability 57 p# biomarker 57 Naturally Occurring 57 Pemphigus Vulgaris 57 Neutralizing Antibodies 57 Amplicor 57 mineralogical analysis 57 F FDG PET 57 Lupus Nephritis 57 Corneal Transplant 57 Rosetta Genomics microRNA 57 Transplant Patients 57 Naive Patients 57 CYP #D# 57 Coronary Arteries 57 Miraculins Announces 57 Photovoltaic Module 57 Prostate Cancer Diagnosis 57 Kidney Transplant Patients 57 ViRexx Announces 57 Hypercholesterolemia 57 FOLOTYN ® 57 First Patient Dosed 57 Detection Kit 57 ORAL Solo 57 Fibroblast 57 Study Evaluating 57 Dose Ranging 57 Glycosylation 57 Announcement acc 57 Overactive Bladder 57 Metallurgical Testwork 57 Phase IIb clinical trials 57 G#DT 57 culture supernatants 57 TLK# 57 Cardiovascular Disease Risk 57 nonclinical studies 57 Endothelial Function 57 IIa trials 57 Demonstrates Statistically Significant 57 relapsed MM 57 Microspheres 57 First Trimester 57 Help Predict 57 parasitological 57 Bare Metal Stent 57 samalizumab 57 Pre IND 57 cTnI 57 Retreatment 57 NASDAQ Delisting Notice 57 Proliferative 57 Genotypic 57 FOR AN OPEN 57 Toremifene 57 Protease 57 Microdosing 57 randomized multicenter trial 57 Microwave Ablation System 57 Relapsing Multiple Sclerosis 57 Leukemias 57 Myocardial Perfusion 57 Signaling Pathway 57 Arthritis Drug 57 QRT PCR 57 Lung Cancer Detection 57 HCV Protease Inhibitor 57 EGFR TKI 57 IND submission 57 Significant Improvements 57 AVERROES 57 AZILECT ® 57 Dilated Cardiomyopathy 57 Anti Bacterial Envelope 57 Mad Cow Testing 57 Receives Orphan Drug Designation 57 element ICP analysis 57 Pemetrexed 57 Antiviral Drug 57 PRESEPT 57 Colorimetric 57 Statin Drugs 57 IIa clinical 57 Serological 57 Genetic Screening 57 immunological responses 57 Induction Chemotherapy 57 Roche AmpliChip 57 Receives Orphan Drug 57 Projected Release Date 57 ARCHITECT HIV 57 Testosterone Patch 57 Chronic Lymphocytic Leukemia 57 Confirmatory testing 57 Pegylated Interferon 57 sitaxsentan 57 Kahalalide F 57 Poniard Pharmaceuticals Announces 57 microbiologic 57 Remission Maintenance 57 Fewer Side Effects 57 Vernakalant 57 Randomized Trials 57 Prognostic Significance 57 AFRS TM 57 CAS #-#-# Market [001] 57 Subtypes 57 serum phosphorous 57 PROCHYMAL 57 Catheter Ablation 57 Stromal Cells 57 Clinical Trial Evaluating 57 Ag Ab Combo 57 Parathyroid Hormone 57 Tasigna prolongs 57 Atypical Hemolytic Uremic Syndrome 57 PCA3 assay 57 CYT# potent vascular disrupting 57 aminotransferase 57 Clostridium difficile Infection 57 ELISA assay 57 Cystatin C 57 Proteinuria 57 Migraine Drug 57 Receives CE Marking 57 Predict Prostate Cancer 57 Retesting 57 KRAS mutation 57 Immunohistochemistry 57 Menstrual Pain 57 Inflammatory Pain 57 Study Showed 57 Pesticide Residue 57 Recombinant EPO 57 Annexin V 57 Cardiomyocytes 57 Novel Oral 57 CT Angiography 57 Dry Powder Inhalers 57 Lung Cancer Survival 57 Herpes Virus 57 Unstable Angina 57 Trabectedin 57 Prostate Cancer Patients 57 Significant Reduction 57 Platinol ® 57 preclinical toxicology 57 pivotal bioequivalence 57 Tipranavir 57 caustic fusion diamond